文献速递免疫规划

使用4 Pillars™实践转化项目在随机对照整群试验中提高青少年HPV疫苗接种率

Improving adolescent HPV vaccination in a randomized controlled cluster trial using the 4 Pillars™ practice Transformation Program.
PubMed 文献 · Vaccine · 2016-11-18

该随机对照整群试验在基层儿科诊所评估4 Pillars™实践转化项目对青少年HPV、MCV和Tdap疫苗接种率的影响。干预组11家、对照组11家诊所入组,9家干预和11家对照完成研究。干预9个月后,干预组HPV疫苗启动率提高10.2个百分点,对照组提高7.3个百分点(P<0.001);实施>10项策略显著增加HPV系列启动的可能性(OR=2.06, 95%CI=1.43, 2.96)。

要点

  • 干预组HPV疫苗启动率提高10.2个百分点 vs 对照组7.3个百分点(P<0.001)。
  • 实施>10项策略显著增加HPV系列启动可能性(OR=2.06, 95%CI=1.43, 2.96)。
  • HPV系列完成率两组间无差异。

核心结论

  • 使用4 Pillars™实践转化项目中>10项策略可有效提高青少年HPV系列启动率。

研究设计与样本

  • 随机对照整群试验,纳入疫苗接种率低于国家目标的11-17岁患者至少50例的基层诊所,干预组11家、对照组11家,完成研究干预组9家、对照组11家。
  • 基线期为2013年7月1日至2014年6月30日,干预期为2014年7月1日至2015年3月31日。

主要发现

  • 队列中38%为11-13岁,50%为女性,18%为非白人,64%有商业保险。
  • 干预组基线HPV启动率平均为52.5%,对照组为61.8%。
  • 9个月后,干预组HPV启动率提高10.2个百分点,对照组提高7.3个百分点(P<0.001)。
  • HPV系列完成率两组间无差异。
  • 实施>10项策略显著增加HPV系列启动的可能性(OR=2.06, 95%CI=1.43, 2.96)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Uptake of meningococcal vaccine (MCV) and tetanus, diphtheria and pertussis (Tdap) vaccine among adolescents has approached Healthy People 2020 goals, but human papillomavirus (HPV) vaccination has not. This study evaluated an intervention using the 4 Pillars™ Practice Transformation Program to increase HPV, MCV and Tdap uptake among adolescents in primary care practices. METHODS: Practices with at least 50 patients 11-17years old with estimated vaccination rates less than national goals, were assigned to intervention (n=11) and control (n=11) groups in a randomized controlled cluster trial; 9 intervention and 11 control sites completed the study. The baseline and active study periods were 7/1/2013-6/30/2014 and 7/1/2014-3/31/2015, respectively. Vaccination and demographic data for patients who had a visit in both study periods were derived from de-identified EMR extractions. Primary outcomes were vaccination rates and percentage point (PP) changes. Data were analyzed in 2015-16. RESULTS: Among the cohort of 10,861 adolescent patients, 38% were 11-13years old; 50% were female; 18% were non-white; and 64% were commercially insured. Average baseline HPV initiation rates were 52.5% for intervention and 61.8% for control groups. After 9months, the intervention sites increased HPV initiation 10.2PP compared with 7.3PP in control sites (P<0.001); HPV series completion rates did not differ between groups. Implementation of >10 strategies to improve rates significantly increased the likelihood of HPV series initiation (OR=2.06, 95% CI=1.43, 2.96). CONCLUSIONS: Using >10 strategies from the 4 Pillars™ Practice Transformation Program is effective for increasing HPV series initiation among adolescents. Clinical trial registry number: NCT02165722.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Zimmerman RK, Moehling KK, Lin CJ, et al. Improving adolescent HPV vaccination in a randomized controlled cluster trial using the 4 Pillars™ practice Transformation Program. Vaccine. 2016. PMID: 27876200. doi:10.1016/j.vaccine.2016.11.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。